We are live on ! Find out more
EW icon

Edwards Lifesciences
EW

Fund managers haven’t disclosed any holdings of EW yet.

EW Hedge Fund Activity: Q1 2026 in Review

1,283 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q1 2026, worth a combined $40.3B — down 6.3% from $43B a quarter earlier.

Sellers outnumbered buyers: 117 funds closed out of EW and 111 opened new positions — a net loss of 6 holders — while 458 trimmed existing stakes and 454 added.

The largest buyer was DZ Bank, adding an estimated $419M. The largest seller was Millennium Management, cutting an estimated $353M.

  • 1,283 institutional investors held Edwards Lifesciences (EW) as of Q1 2026, down from 1,313 in Q4 2025.
  • Funds reported $40.3B of Edwards Lifesciences stock for Q1 2026, down 6.3% quarter-over-quarter.
  • 111 funds opened new Edwards Lifesciences positions in Q1 2026 and 117 closed out, a net change of -6 holders.
  • The largest Edwards Lifesciences buyer in Q1 2026 was DZ Bank, an estimated $419M added.
  • The largest Edwards Lifesciences seller in Q1 2026 was Millennium Management, an estimated $353M sold.

Based on aggregated 13F filings for Q1 2026.